Advertisement
Research Article Free access | 10.1172/JCI118791
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, The Netherlands.
Find articles by Kluijtmans, L. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, The Netherlands.
Find articles by Boers, G. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, The Netherlands.
Find articles by Stevens, E. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, The Netherlands.
Find articles by Renier, W. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, The Netherlands.
Find articles by Kraus, J. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, The Netherlands.
Find articles by Trijbels, F. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, The Netherlands.
Find articles by van den Heuvel, L. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, The Netherlands.
Find articles by Blom, H. in: JCI | PubMed | Google Scholar
Published July 15, 1996 - More info
We determined the molecular basis of cystathionine beta-synthase (CBS) deficiency in a partially pyridoxine-responsive homocystinuria patient. Direct sequencing of the entire CBS cDNA revealed the presence of a homozygous G1330A transition. This mutation causes an amino acid change from aspartic acid to asparagine (D444N) in the regulatory domain of the protein and abolishes a TaqI restriction site at DNA level. Despite the homozygous mutation, CBS activities in extracts of cultured fibroblasts of this patient were not in the homozygous but in the heterozygous range. Furthermore, we observed no stimulation of CBS activity by S-adenosylmethionine, contrary to a threefold stimulation in control fibroblast extract. The mutation was introduced in an E. coli expression system and CBS activities were measured after addition of different S-adenosylmethionine concentrations (0-200 microM). Again, we observed a defective stimulation of CBS activity by S-adenosylmethionine in the mutated construct, whereas the normal construct showed a threefold stimulation in activity. These data suggest that this D444N mutation interferes in S-adenosylmethionine regulation of CBS. Furthermore, it indicates the importance of S-adenosylmethionine regulation of the transsulfuration pathway in homocysteine homeostasis in humans.